Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07838064 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Detection of Biomarkers for Prosthetic Infection Type - (DEBIT)

Study acronym: DEBIT
StatusRecruiting
PhaseNot applicable
Started2026-02-13
View on ClinicalTrials.gov ↗
Prosthetic joint infection (PJI) is a significant cause of failure in hip and knee arthroplasty and is often difficult to diagnose using current methods. This study aims to identify novel biomarkers for early and accurate diagnosis of PJI using nanopore sequencing technology (Oxford Nanopore Technologies). By analysing microbial profiles and host immune responses in samples from patients undergoing revision surgery, the study will compare infected and non-infected cases. Biomarkers will be investigated in periprosthetic tissue as well as less invasive sample types, including synovial fluid and blood, with the goal of improving early diagnosis and guiding future treatment strategies.
Trial Details
NCT Number NCT07838064
Lead Sponsor Portsmouth Hospitals NHS Trust
Collaborators: University of Portsmouth
Conditions Prosthetic Joint Infection (PJI)
Enrollment 40 participants
Start Date 2026-02-13
Primary Completion 2026-10-31 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-24